CMS Administrator Norwalk Says Releasing Data On Medicare Prescription Drug Benefit Discounts Would Undermine Negotiations
Main Category: Medicare / Medicaid / SCHIPAlso Included In: Pharma Industry / Biotech Industry
Article Date: 07 Mar 2007 - 10:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
CMS Administrator Leslie Norwalk in a letter to lawmakers on Thursday said that the agency will not disclose information on discounts obtained by pharmacy benefit managers for Medicare prescription drug plans, CQ HealthBeat reports. House Oversight and Government Reform Committee Chair Henry Waxman (D-Calif.) last month sent letters to Medicare drug plans requesting data to determine the size of drug plans' profits and whether discounts negotiated by PBMs with drug makers were passed on to beneficiaries. Rep. Thomas Davis (R-Va.) sent a letter to CMS requesting the information. Norwalk in the letter wrote, "Several independent entities, including the Congressional Budget Office and the Federal Trade Commission, have concluded that public disclosure of negotiated price concessions will reduce the ability of pharmacy benefit managers and plans to negotiate significant discounts." She continued, "We recognize that Congress has a legitimate role in overseeing" the Medicare drug benefit and "are reviewing other authorities under which we may be able to make certain information available." Norwalk noted an FTC analysis finding that collusion and higher prices are more likely to result when competitors know prices charged by other companies. She also noted a CBO report that found disclosing the discount data could increase the cost of the drug benefit by as much as $40 billion over 10 years. In a separate letter sent to Waxman on Thursday, the Pharmaceutical Care Management Association -- the lobby that represents PBMs -- said that release of the data would increase prices for the drug benefit and beneficiaries. Association spokesperson Phil Blando said, "To the extent that any information is provided to the committee, whether from CMS or individual companies, we think it's critical that the committee safeguard the information" (Reichard, CQ HealthBeat, 3/2).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our medicare / medicaid / schip section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/64554.php>
APA
http://www.medicalnewstoday.com/releases/64554.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




